BioAB Strategies Ltd.

June 13, 2014 19:34 ET

BioAB Strategies Ltd. Announces Closing of Non-Brokered Financing

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 13, 2014) - BioAB Strategies Ltd. (the "Company") is pleased to announce that it has closed its previously announced non-brokered financing (the "Financing") and has issued a total of 5,000,000 units (the "Units") for aggregate proceeds of $200,000, at a price of $0.04 per Unit. Each Unit is comprised of one common share and one share purchase warrants, exercisable to purchase one common share for one year at a price of $0.06.

The proceeds from the Financing will be used for working capital requirements and to develop the Company's business plan.

BioAB Strategies Ltd. is a private Canadian bio-pharmaceutical reporting issuer which holds a licensed patent portfolio.

Contact Information

  • Bruce Schmidt
    Chief Executive Officer
    Chief Financial Officer & Director
    Phone: 604-760-0160